Patents by Inventor Teresa Cabezon Silva

Teresa Cabezon Silva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the production of immunogenic compositions
    Patent number: 8597656
    Abstract: The present invention relates to a process for producing immunogenic polypeptides, comprising reducing disulfide bonds and blocking the resulting free thiol group with a blocking agent. The immunogenic peptides comprise a fragment of MAGE A3.
    Type: Grant
    Filed: December 13, 2011
    Date of Patent: December 3, 2013
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Teresa Cabezon Silva, Joseph Cohen, Moncef Mohamed Slaoui, Carlota Vinals Bassols
  • PROCESS FOR THE PRODUCTION OF IMMUNOGENIC COMPOSITIONS
    Publication number: 20120269835
    Abstract: The present invention relates to a process for producing immunogenic polypeptides, comprising reducing disulfide bonds and blocking the resulting free thiol group with a blocking agent. The immunogenic peptides comprise a fragment of MAGE A3.
    Type: Application
    Filed: December 13, 2011
    Publication date: October 25, 2012
    Inventors: Teresa Cabezon Silva, Joseph Cohen, Moncef Mohamed Slaoui, Carlota Vinals Bassols
  • Process for the production of immunogenic compositions
    Patent number: 8044183
    Abstract: The present invention relates to a process for producing immunogenic polypeptides, comprising reducing disulfide bonds and blocking the resulting free thiol group with a blocking agent. The immunogenic peptides comprise a fragment of MAGE A3.
    Type: Grant
    Filed: March 12, 2010
    Date of Patent: October 25, 2011
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Teresa Cabezon Silva, Joseph Cohen, Moncef Mohamed Slaoui, Carlota Vinals Bassols
  • Process for the Production of Immunogenic Compositions
    Publication number: 20100204458
    Abstract: The present invention relates to a process for producing immunogenic polypeptides, comprising reducing disulfide bonds and blocking the resulting free thiol group with a blocking agent. The immunogenic peptides comprise a fragment of MAGE A3.
    Type: Application
    Filed: March 12, 2010
    Publication date: August 12, 2010
    Inventors: Teresa Cabezon Silva, Joseph Cohen, Moncef Mohamed Slaoui, Carlota Vinals Bassols
  • Tumour-specific animal proteins
    Publication number: 20060171953
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.
    Type: Application
    Filed: December 13, 2005
    Publication date: August 3, 2006
    Inventors: Teresa Cabezon-Silva, Jean-Pol Cassart, Thierry Coche, Swann Romain Gaulis, Carlota Vinals Y De Bassols
  • Recombinant papillomavirus vaccine and method for production and treatment
    Publication number: 20020182221
    Abstract: The present invention relates to fusions proteins, comprising a protein or part of a protein that provides T helper epitopes and an antigen from a human-papilloma virus. In particular the invention relates to fusion proteins comprising an E6 or E7 protein from HPV strain 16 or 18 linked to protein D from Haemophilus influenza B. The invention also provides vaccine compositions that are useful in the treatment or prophylaxis of human papilloma induced tumors.
    Type: Application
    Filed: November 1, 2001
    Publication date: December 5, 2002
    Applicant: SmithKline Beecham Biologicals
    Inventors: Claudine Bruck, Teresa Cabezon Silva, Anne-Marie Eva Fernande Delisse, Catherine Marie Ghislaine Gerard, Angela Lombardo-Bencheikh
  • Recombinant papillomavirus vaccine and method for production and treatment
    Patent number: 6342224
    Abstract: The present invention relates to fusions proteins, comprising a protein or part of a protein that provides T helper epitopes and an antigen from a human-papilloma virus. In particular the invention relates to fusion proteins comprising an E6 or E7 protein from HPV strain 16 or 18 linked to protein D from Haemophilus influenza B. The invention also provides vaccine compositions that are useful in the treatment or prophylaxis of human papilloma induced tumours.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: January 29, 2002
    Assignee: SmithKline Beecham Biologicals, S.A.
    Inventors: Claudine Bruck, Teresa Cabezon Silva, Anne-Marie Eva Fernande Delisse, Catherine Marie Ghislaine Gerard, Angela Lombardo-Bencheikh